nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
This report aims to provide a comprehensive presentation of the global market for Insulin Glargine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Glargine. This report contains market size and forecasts of Insulin Glargine in global, including the following market information:
Global Insulin Glargine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Insulin Glargine Market Sales, 2018-2023, 2024-2029, (M mL)
Global top five Insulin Glargine companies in 2022 (%)
The global Insulin Glargine market was valued at US$ 6902.2 million in 2022 and is projected to reach US$ 8978.2 million by 2029, at a CAGR of 3.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Insulin Glargine key players include Sanofi-Aventis, Ganlee, etc. Global top two manufacturers hold a share nearly 50%.
USA is the largest market, with a share over 60%, followed by China, and Europe, both have a share about 35 percent.
In terms of product, Pre-filled Syringe is the largest segment, with a share about 75%. And in terms of application, the largest application is Treat type2 diabetes, followed by Treat type1 diabetes.
We surveyed the Insulin Glargine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insulin Glargine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M mL)
Global Insulin Glargine Market Segment Percentages, by Type, 2022 (%)
Single Dose Vial
Pre-filled Syringe
Global Insulin Glargine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M mL)
Global Insulin Glargine Market Segment Percentages, by Application, 2022 (%)
Treat Type2 Diabetes
Treat Type1 Diabetes
Global Insulin Glargine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M mL)
Global Insulin Glargine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Insulin Glargine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Insulin Glargine revenues share in global market, 2022 (%)
Key companies Insulin Glargine sales in global market, 2018-2023 (Estimated), (M mL)
Key companies Insulin Glargine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi-Aventis
Ganlee
Biocon
Outline of Major Chapters:
Chapter 1: Introduces the definition of Insulin Glargine, market overview.
Chapter 2: Global Insulin Glargine market size in revenue and volume.
Chapter 3: Detailed analysis of Insulin Glargine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Insulin Glargine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Insulin Glargine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Insulin Glargine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insulin Glargine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insulin Glargine Overall Market Size
2.1 Global Insulin Glargine Market Size: 2022 VS 2029
2.2 Global Insulin Glargine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Insulin Glargine Sales: 2018-2029
3 Company Landscape
3.1 Top Insulin Glargine Players in Global Market
3.2 Top Global Insulin Glargine Companies Ranked by Revenue
3.3 Global Insulin Glargine Revenue by Companies
3.4 Global Insulin Glargine Sales by Companies
3.5 Global Insulin Glargine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Insulin Glargine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Insulin Glargine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Insulin Glargine Players in Global Market
3.8.1 List of Global Tier 1 Insulin Glargine Companies
3.8.2 List of Global Tier 2 and Tier 3 Insulin Glargine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Insulin Glargine Market Size Markets, 2022 & 2029
4.1.2 Single Dose Vial
4.1.3 Pre-filled Syringe
4.2 By Type - Global Insulin Glargine Revenue & Forecasts
4.2.1 By Type - Global Insulin Glargine Revenue, 2018-2023
4.2.2 By Type - Global Insulin Glargine Revenue, 2024-2029
4.2.3 By Type - Global Insulin Glargine Revenue Market Share, 2018-2029
4.3 By Type - Global Insulin Glargine Sales & Forecasts
4.3.1 By Type - Global Insulin Glargine Sales, 2018-2023
4.3.2 By Type - Global Insulin Glargine Sales, 2024-2029
4.3.3 By Type - Global Insulin Glargine Sales Market Share, 2018-2029
4.4 By Type - Global Insulin Glargine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insulin Glargine Market Size, 2022 & 2029
5.1.2 Treat Type2 Diabetes
5.1.3 Treat Type1 Diabetes
5.2 By Application - Global Insulin Glargine Revenue & Forecasts
5.2.1 By Application - Global Insulin Glargine Revenue, 2018-2023
5.2.2 By Application - Global Insulin Glargine Revenue, 2024-2029
5.2.3 By Application - Global Insulin Glargine Revenue Market Share, 2018-2029
5.3 By Application - Global Insulin Glargine Sales & Forecasts
5.3.1 By Application - Global Insulin Glargine Sales, 2018-2023
5.3.2 By Application - Global Insulin Glargine Sales, 2024-2029
5.3.3 By Application - Global Insulin Glargine Sales Market Share, 2018-2029
5.4 By Application - Global Insulin Glargine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Insulin Glargine Market Size, 2022 & 2029
6.2 By Region - Global Insulin Glargine Revenue & Forecasts
6.2.1 By Region - Global Insulin Glargine Revenue, 2018-2023
6.2.2 By Region - Global Insulin Glargine Revenue, 2024-2029
6.2.3 By Region - Global Insulin Glargine Revenue Market Share, 2018-2029
6.3 By Region - Global Insulin Glargine Sales & Forecasts
6.3.1 By Region - Global Insulin Glargine Sales, 2018-2023
6.3.2 By Region - Global Insulin Glargine Sales, 2024-2029
6.3.3 By Region - Global Insulin Glargine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Insulin Glargine Revenue, 2018-2029
6.4.2 By Country - North America Insulin Glargine Sales, 2018-2029
6.4.3 US Insulin Glargine Market Size, 2018-2029
6.4.4 Canada Insulin Glargine Market Size, 2018-2029
6.4.5 Mexico Insulin Glargine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Insulin Glargine Revenue, 2018-2029
6.5.2 By Country - Europe Insulin Glargine Sales, 2018-2029
6.5.3 Germany Insulin Glargine Market Size, 2018-2029
6.5.4 France Insulin Glargine Market Size, 2018-2029
6.5.5 U.K. Insulin Glargine Market Size, 2018-2029
6.5.6 Italy Insulin Glargine Market Size, 2018-2029
6.5.7 Russia Insulin Glargine Market Size, 2018-2029
6.5.8 Nordic Countries Insulin Glargine Market Size, 2018-2029
6.5.9 Benelux Insulin Glargine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Insulin Glargine Revenue, 2018-2029
6.6.2 By Region - Asia Insulin Glargine Sales, 2018-2029
6.6.3 China Insulin Glargine Market Size, 2018-2029
6.6.4 Japan Insulin Glargine Market Size, 2018-2029
6.6.5 South Korea Insulin Glargine Market Size, 2018-2029
6.6.6 Southeast Asia Insulin Glargine Market Size, 2018-2029
6.6.7 India Insulin Glargine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Insulin Glargine Revenue, 2018-2029
6.7.2 By Country - South America Insulin Glargine Sales, 2018-2029
6.7.3 Brazil Insulin Glargine Market Size, 2018-2029
6.7.4 Argentina Insulin Glargine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Insulin Glargine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Insulin Glargine Sales, 2018-2029
6.8.3 Turkey Insulin Glargine Market Size, 2018-2029
6.8.4 Israel Insulin Glargine Market Size, 2018-2029
6.8.5 Saudi Arabia Insulin Glargine Market Size, 2018-2029
6.8.6 UAE Insulin Glargine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi-Aventis
7.1.1 Sanofi-Aventis Company Summary
7.1.2 Sanofi-Aventis Business Overview
7.1.3 Sanofi-Aventis Insulin Glargine Major Product Offerings
7.1.4 Sanofi-Aventis Insulin Glargine Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi-Aventis Key News & Latest Developments
7.2 Ganlee
7.2.1 Ganlee Company Summary
7.2.2 Ganlee Business Overview
7.2.3 Ganlee Insulin Glargine Major Product Offerings
7.2.4 Ganlee Insulin Glargine Sales and Revenue in Global (2018-2023)
7.2.5 Ganlee Key News & Latest Developments
7.3 Biocon
7.3.1 Biocon Company Summary
7.3.2 Biocon Business Overview
7.3.3 Biocon Insulin Glargine Major Product Offerings
7.3.4 Biocon Insulin Glargine Sales and Revenue in Global (2018-2023)
7.3.5 Biocon Key News & Latest Developments
8 Global Insulin Glargine Production Capacity, Analysis
8.1 Global Insulin Glargine Production Capacity, 2018-2029
8.2 Insulin Glargine Production Capacity of Key Manufacturers in Global Market
8.3 Global Insulin Glargine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Insulin Glargine Supply Chain Analysis
10.1 Insulin Glargine Industry Value Chain
10.2 Insulin Glargine Upstream Market
10.3 Insulin Glargine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Insulin Glargine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Insulin Glargine in Global Market
Table 2. Top Insulin Glargine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Insulin Glargine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Insulin Glargine Revenue Share by Companies, 2018-2023
Table 5. Global Insulin Glargine Sales by Companies, (M mL), 2018-2023
Table 6. Global Insulin Glargine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Insulin Glargine Price (2018-2023) & (USD/mL)
Table 8. Global Manufacturers Insulin Glargine Product Type
Table 9. List of Global Tier 1 Insulin Glargine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insulin Glargine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Insulin Glargine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Insulin Glargine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Insulin Glargine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Insulin Glargine Sales (M mL), 2018-2023
Table 15. By Type - Global Insulin Glargine Sales (M mL), 2024-2029
Table 16. By Application ? Global Insulin Glargine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Insulin Glargine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Insulin Glargine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Insulin Glargine Sales (M mL), 2018-2023
Table 20. By Application - Global Insulin Glargine Sales (M mL), 2024-2029
Table 21. By Region ? Global Insulin Glargine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Insulin Glargine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Insulin Glargine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Insulin Glargine Sales (M mL), 2018-2023
Table 25. By Region - Global Insulin Glargine Sales (M mL), 2024-2029
Table 26. By Country - North America Insulin Glargine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Insulin Glargine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Insulin Glargine Sales, (M mL), 2018-2023
Table 29. By Country - North America Insulin Glargine Sales, (M mL), 2024-2029
Table 30. By Country - Europe Insulin Glargine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Insulin Glargine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Insulin Glargine Sales, (M mL), 2018-2023
Table 33. By Country - Europe Insulin Glargine Sales, (M mL), 2024-2029
Table 34. By Region - Asia Insulin Glargine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Insulin Glargine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Insulin Glargine Sales, (M mL), 2018-2023
Table 37. By Region - Asia Insulin Glargine Sales, (M mL), 2024-2029
Table 38. By Country - South America Insulin Glargine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Insulin Glargine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Insulin Glargine Sales, (M mL), 2018-2023
Table 41. By Country - South America Insulin Glargine Sales, (M mL), 2024-2029
Table 42. By Country - Middle East & Africa Insulin Glargine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Insulin Glargine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Insulin Glargine Sales, (M mL), 2018-2023
Table 45. By Country - Middle East & Africa Insulin Glargine Sales, (M mL), 2024-2029
Table 46. Sanofi-Aventis Company Summary
Table 47. Sanofi-Aventis Insulin Glargine Product Offerings
Table 48. Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue (US$, Mn) and Average Price (USD/mL) (2018-2023)
Table 49. Sanofi-Aventis Key News & Latest Developments
Table 50. Ganlee Company Summary
Table 51. Ganlee Insulin Glargine Product Offerings
Table 52. Ganlee Insulin Glargine Sales (M mL), Revenue (US$, Mn) and Average Price (USD/mL) (2018-2023)
Table 53. Ganlee Key News & Latest Developments
Table 54. Biocon Company Summary
Table 55. Biocon Insulin Glargine Product Offerings
Table 56. Biocon Insulin Glargine Sales (M mL), Revenue (US$, Mn) and Average Price (USD/mL) (2018-2023)
Table 57. Biocon Key News & Latest Developments
Table 58. Insulin Glargine Production Capacity (M mL) of Key Manufacturers in Global Market, 2021-2023 (M mL)
Table 59. Global Insulin Glargine Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Insulin Glargine Production by Region, 2018-2023 (M mL)
Table 61. Global Insulin Glargine Production by Region, 2024-2029 (M mL)
Table 62. Insulin Glargine Market Opportunities & Trends in Global Market
Table 63. Insulin Glargine Market Drivers in Global Market
Table 64. Insulin Glargine Market Restraints in Global Market
Table 65. Insulin Glargine Raw Materials
Table 66. Insulin Glargine Raw Materials Suppliers in Global Market
Table 67. Typical Insulin Glargine Downstream
Table 68. Insulin Glargine Downstream Clients in Global Market
Table 69. Insulin Glargine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Insulin Glargine Segment by Type in 2022
Figure 2. Insulin Glargine Segment by Application in 2022
Figure 3. Global Insulin Glargine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Insulin Glargine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Insulin Glargine Revenue, 2018-2029 (US$, Mn)
Figure 7. Insulin Glargine Sales in Global Market: 2018-2029 (M mL)
Figure 8. The Top 3 and 5 Players Market Share by Insulin Glargine Revenue in 2022
Figure 9. By Type - Global Insulin Glargine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Insulin Glargine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Insulin Glargine Sales Market Share, 2018-2029
Figure 12. By Type - Global Insulin Glargine Price (USD/mL), 2018-2029
Figure 13. By Application - Global Insulin Glargine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Insulin Glargine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Insulin Glargine Sales Market Share, 2018-2029
Figure 16. By Application - Global Insulin Glargine Price (USD/mL), 2018-2029
Figure 17. By Region - Global Insulin Glargine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Insulin Glargine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Insulin Glargine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Insulin Glargine Sales Market Share, 2018-2029
Figure 21. By Country - North America Insulin Glargine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Insulin Glargine Sales Market Share, 2018-2029
Figure 23. US Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Insulin Glargine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Insulin Glargine Sales Market Share, 2018-2029
Figure 28. Germany Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 29. France Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Insulin Glargine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Insulin Glargine Sales Market Share, 2018-2029
Figure 37. China Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 41. India Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Insulin Glargine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Insulin Glargine Sales Market Share, 2018-2029
Figure 44. Brazil Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Insulin Glargine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Insulin Glargine Sales Market Share, 2018-2029
Figure 48. Turkey Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Insulin Glargine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Insulin Glargine Production Capacity (M mL), 2018-2029
Figure 53. The Percentage of Production Insulin Glargine by Region, 2022 VS 2029
Figure 54. Insulin Glargine Industry Value Chain
Figure 55. Marketing Channels
